Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Didier Hauglustaine is active.

Publication


Featured researches published by Didier Hauglustaine.


Nephron | 1980

Silicon Nephropathy: a Possible Occupational Hazard

Didier Hauglustaine; B Van Damme; P. Daenens; Paul Michielsen

A 37-year-old white male, working in a tile factory, presented proteinuria with no obvious tubular dysfunctional. Renal biopsy disclosed a mild focal segmental proliferative glomerulonephritis. Distinct alterations were found by electron microscopy, especially in the proximal tubular cells. Because of a history of heavy dust exposure the silicon content was determined in the kidney biopsy tissue. The finding of 150 mg/kg silicon on tissue dry weight supports the diagnosis of silicon nephropathy.


The Lancet | 1981

OESTROGEN CONTAINING ORAL CONTRACEPTIVES, DECREASED PROSTACYCLIN PRODUCTION, AND HAEMOLYTIC URAEMIC SYNDROME

Didier Hauglustaine; Y. Vanrenterghem; Paul Michielsen; B. Van Damme

Dr. Ylikorkala and colleagues (January 3, p. 42) present evidence for lowered (PGI2) prostacyclin production in normal women after prolonged use of estrogen-containing (OCs) oral contraceptives but not after use of a progestagen-only OC. We have seen a 23-year old multiparous normotensive woman whohad a (HUS) hemolytic uremic syndrome 5 months postpartum and 4 months after starting on a combined OC (Mestranol + chlormadinone acetate). HUS recurred 8 years later, 5 years after a successful cadaver kidney transplantation and 10 months after resumption of combined OC intake (thinyl estradiol levenorgestrel). In the interim, a progestagen-only OC (lynestrenol) was used without problems for 7 years. Other causes of HUS (systemic disease, malignant hypertension, transplant rejection, infection) were excluded. Details of this case will be published elsewhere. A disorder in PGI2 production has been proposed as the underlying basic abnormality in some patients with HUS. In the light of the observation of Ylikorkala et al, the recurrence of HUS in a transplanted kidney after resumption of an estrogen-containing OC could be seen as a confirmation of the role of PGI2 in HUS. HUS-related to OCs is rare is view of the large numbers of women on the pill; thus a genetically determined predisposition is likely. This is supported by the observation of HUS in adult sisters taking OCs. Further data are needed to discover if this predisposition is a dificient production of PGI2 as suggested by Remuzzi et al.


Digestion | 1985

Protein-Losing Enteropathy in Systemic Lupus erythematosus

Jan Monballyu; Didier Hauglustaine; Karel Geboes; V. Desmet; Paul Michielsen

A 33-year-old woman presented a recurrent steroid-sensitive protein-losing enteropathy as the major manifestation of systemic lupus erythematosus. An increased capillary permeability for proteins is considered to be the most likely explanation.


Nephron | 1985

Bicarbonate dialysis using a single concentrate.

Josy Martens; Didier Hauglustaine; René Verberckmoes; Paul Michielsen

Bicarbonate Dialysis Using a Single Concentrate J. Josy Martens D. Didier Hauglustaine R. René Verberckmoes P. Paul Michielsen Josy Martens, MD, Didier Hauglustaine, MD, René Verberckmoes, MD, Paul Michielsen, MD, Division of Nephrology, Universitair Ziekenhuis Gasthuisberg, Herestraat, 49, B-3000 Leuven (Belgium) Dear Sir, Haemodialysis with bicarbonate-containing dialysate may offer many advantages over acetate dialysis as improved vascular stability, prevention of dialysis-induced hypoxaemia, more adequate base repletion and improved patient well-being [1–4]. Bicarbonate dialysis is now more frequently used since automated techniques have been developed to prevent precipitation of calcium and magnesium carbonates. However, the present systems require a two-stream proportioning and monitoring device and two separate concentrates. These systems are more complicated and expensive than those used in standard acetate dialysis [4, 5]. We propose an alternative method for bicarbonate dialysis that circumvents the aforementioned problems. Our method of bicarbonate dialysis uses a single concentrate, composed of sodium chloride and sodium bicarbonate. Calcium, magnesium and potassium chloride are omitted from the dialysate but administered by a continuous intravenous infusion. The concentrate was prepared long in advance by dissolving sodium choride and sodium bicarbonate in deionized water to achieve, after dilution 1/12, a final dialysate composition of Na+ 137 mmol/l, Cl 102 mmol/l and HCOj 35 mmol/l. The concentrate and reverse osmosis water were mixed and monitored by a conventional single patient dialysis machine ( < Monitral > , Hospal). A sterile solution containing CaCl2–2 aqua 51.35 g/l, KC115.53 g/l and MgCl2 · 6 aqua 21.18 g/l, was infused by a calibrated pump at a constant rate of 0.5 ml/min into the blood being returned to the patient (i.e. 7 mg elemental calcium/min [6] and 25 mmol potassium and magnesium/4 h). In the event of a shutdown of the blood pump the infusion was stopped. Table I. Laboratory measurements (preand postdialysis) in 7 patients during six bicarbonate dialysis (mmol/l)


Annals of Internal Medicine | 1983

Urinary Erythrocytes and Glomerular Disease

Didier Hauglustaine; Willy Bollens; Paul Michielsen

Excerpt To the editor: In a recent editorial Morrin reminds us of the importance of microscopic examination of freshly voided urine in detecting a glomerulopathy (1). He emphasizes a careful search...


The Lancet | 1986

HAEMODIALYSIS MEMBRANES, SERUM β2-MICROGLOBULIN, AND DIALYSIS AMYLOIDOSIS

Didier Hauglustaine; Mark Waer; Paul Michielsen; Jozef Goebels; Michel Vandeputte


Thrombosis and Haemostasis | 1989

Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients.

Chris Van Geet; Didier Hauglustaine; Luc Verresen; Vanrusselt M; Jos Vermylen


Nephrology Dialysis Transplantation | 1988

Corticosteroid Withdrawal Syndrome in Dialysis Patients

Luc Verresen; Yves Vanrenterghem; Mark Waer; Didier Hauglustaine; Paul Michielsen


Nephron | 1992

Effect of Recombinant Human Erythropoietin on Reticulocyte Age in Hemodialysis Patients

Pierre Zachee; L. Van Hove; Didier Hauglustaine; L. Veressen; M. A. Boogaerts


Digestion | 1985

Contents, Vol 31, 1985

Gábor Varga; Carmelo Scarpignato; M. Papp; Kazue Goso; Kazuhiko Ishihara; Susumu Ohara; Masao Kakei; Kyoko Hotta; B. de Waele; R. Kiekens; Michael M. Kochen; Karl Wegscheider; Heinz-Harold Abholz; M.Y. Valinietse; V.K. Bauman; Y.Y. Galvanovsky; F. Pérez-Aguilar; M. Bretó; B. Alegre; J. Berenguer; D.J. O’Shaughnessy; R.G. Long; Thomas E. Adrian; N.D. Christofides; Mohammad A. Ghatei; D.L. Sarson; Stephen R. Bloom; Jan Monballyu; Didier Hauglustaine; Karel Geboes

Collaboration


Dive into the Didier Hauglustaine's collaboration.

Top Co-Authors

Avatar

Paul Michielsen

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Jan Monballyu

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Karel Geboes

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Mark Waer

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Papp

Hungarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge